Literature DB >> 6147719

Ketoconazole for prostate cancer.

G Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6147719     DOI： 10.1016/s0140-6736(84)91253-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  The endocrine effects of ketoconazole.

Authors:  N Sonino
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

Review 2.  Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics.

Authors:  Cara H Nelson; Brian R Buttrick; Nina Isoherranen
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

3.  Antitumor effects of ketoconazole and trifluoperazine in murine T-cell lymphomas.

Authors:  S Naftalovich; E Yefenof; Y Eilam
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  New diphenylphosphane derivatives of ketoconazole are promising antifungal agents.

Authors:  Rodrigo F M de Almeida; Filipa C Santos; Krzysztof Marycz; Michalina Alicka; Anna Krasowska; Jakub Suchodolski; Jarosław J Panek; Aneta Jezierska; Radosław Starosta
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.